Press release
Non-alcoholic Steatohepatitis Market Will Hit at a Highest CAGR of 56.15% by 2026 with Leading Players ALLERGAN, Zydus Cadila, Conatus Pharmaceuticals Inc, Galmed Pharmaceuticals Ltd
Non-alcoholic Steatohepatitis Market
Get Sample Copy of Global Non-alcoholic Steatohepatitis Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-non-alcoholic-steatohepatitis-market
Few of the major competitors currently working in the global non-alcoholic steatohepatitis market are
ALLERGAN,
Zydus Cadila,
Conatus Pharmaceuticals Inc,
Galmed Pharmaceuticals Ltd,
Gemphire,
Genfit SA,
Gilead Sciences, Inc.,
Intercept Pharmaceuticals, Inc.,
Novartis AG,
Shire,
Enzo Biochem Inc.,
Novo Nordisk A/S,
Immuron,
Pfizer Inc.,
Algernon Pharmaceuticals,
Celerion,
NuSirt Biopharma,
Perspectum Diagnostics.,
Boehringer Ingelheim International GmbH and others.
Market Definition:
Nonalcoholic steatohepatitis (NASH) is a kind of a non-alcoholic fatty liver disease (NAFLD) which usually occurs when fat is collected in the liver. It usually causes inflammation and also damages the liver cell. NASH usually occurs on people who don’t consume alcohol. Itis very common in patients with conditions such as hypertension, type 2 diabetes, high blood lipid, heart disease, and others. NASH can also cause problems like liver cancer and cirrhosis. According to researchers, about 3 to 12 percentage of population in United States is suffering from nonalcoholic steatohepatitis.
Market Drivers
Increasing cases of diabetes and obesity is driving the growth of the market
Growing Nonalcoholic steatohepatitis (NASH) affected population worldwide will also drive the market growth
Rising healthcare expenditure will also propel the market growth
Increasing launches of pipeline drugs will also contribute as a factor for the growth of this market
Market Restraints
Lack of proper diagnostic technologies for Nonalcoholic steatohepatitis (NASH) will restrain the market growth
Less demand in the underdeveloped countries is another factor restraining the market growth
Segmentation: Global Non-alcoholic Steatohepatitis Market
By Drug Type
o Vitamin E & Pioglitazone
o Ocaliva
o Obeticholic acid
o Elafibranor
o Selonsertib & Cenicriviroc
o Others
By Sales Channel
o Hospital Pharmacy
o Online Provider
o Retail Pharmacy
By Disease Cause
o Hypertension
o Heart Disease
o High Blood Lipid
o Type 2 Diabetes
o Obesity
End User
o Hospitals
o Clinics
o Homecare settings
By Geography
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Enquire for customization in Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-non-alcoholic-steatohepatitis-market
Key Developments in the Market:
In July 2019, Altimmune, Inc announced that they have acquired Spitfire Pharma, Inc along with their product candidate SP-1373 to treat non-alcoholic steatohepatitis (NASH). The main aim of the acquisition is to help the company to meet the requirement of the people for treatment of Nonalcoholic steatohepatitis (NASH). This acquisition will strengthen the company’s position in the market and will provide better treatment to their patients
In July 2019, InSphero AG launched their new 3D InSight Human Liver Disease Discovery Platform which is specially designed for the safety testing of nonalcoholic steatohepatitis drugs and nonalcoholic fatty liver disease. The main aim of this launch is to meet the increasing demand of research community for efficient and fast screening of the drug candidates
Competitive Analysis:
Global non-alcoholic steatohepatitis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of non-alcoholic steatohepatitis market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Reasons to Purchase this Report
Current and future of global non-alcoholic steatohepatitis market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Table of Contents:
Introduction
Market Segmentation
Market Overview
Executive Summary
Premium Insights
Global, By Component
Product Type
Delivery
Industry Type
Geography
Company Landscape
Company Profiles
Related Reports
View Detailed Table of Content @ https://www.databridgemarketresearch.com/toc/?dbmr=global-non-alcoholic-steatohepatitis-market
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-alcoholic Steatohepatitis Market Will Hit at a Highest CAGR of 56.15% by 2026 with Leading Players ALLERGAN, Zydus Cadila, Conatus Pharmaceuticals Inc, Galmed Pharmaceuticals Ltd here
News-ID: 2158223 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
